Sensex, Nifty 50 as we speak: Inventory market opens in crimson as auto, FMCG, and actual property shares fall

Related

Share

Sensex, Nifty 50 as we speak: The inventory market fell into the crimson for the fourth consecutive time this week after opening on Thursday, February 20, as auto, FMCG, and actual property shares dropped.

Sensex, Nifty 50 as we speak: Individuals stroll previous the Bombay Inventory Alternate (BSE) constructing in Mumbai, India, March 9, 2020(Francis Mascarenhas/Reuters)

At 9:20 am IST, the benchmark BSE Sensex was down 310.64 factors or 0.41%, reaching 75,628.54. The broader NSE Nifty opened 74.00 factors down or 0.32% within the crimson, reaching 22,858.90.

Additionally Learn: Former OpenAI CTO Mira Murati is launching her personal rival AI startup Pondering Machines Lab

Which shares fell essentially the most?

Among the many 30 Sensex shares, Mahindra & Mahindra fell essentially the most by 2.12%, buying and selling at ₹2,698.75. This was adopted by ITC, which fell 1.40%, buying and selling at ₹400.80, and HDFC Financial institution, which fell by 1.18%, buying and selling at ₹1,706.50

Solely 8 of the 30 Sensex shares have been within the inexperienced.

Additionally Learn: Hurun India 500 checklist: Reliance, TCS, and HDFC Financial institution amongst India’s Most worthy firms

How did particular person sectors carry out?

Among the many Nifty sectoral indices, the Nifty Auto Index fell essentially the most by 0.89%, reaching 21,614.65, adopted by Nifty FMCG, which fell 0.77%, reaching 51,956.80, and the Nifty Realty, which fell 0.62%, reaching 840.70.

Additionally Learn: Gold costs hover close to report excessive as Trump tariff fears enhance its secure haven attraction

How did the inventory market carry out through the earlier session?

The inventory market closed comparatively flat, however within the crimson after the final session ended on Wednesday, February 19, 2025, with IT, healthcare, and pharma shares declining essentially the most.

This marked the second consecutive flat shut of the week which was barely in direction of the crimson.

The Sensex closed 28.21 factors or 0.04% within the crimson, reaching 75,939.18. The Nifty was down by 12.40 factors or 0.05% within the crimson, closing at 22,932.90.

“The Nifty ended slightly down yesterday but the script was familiar – the opening slump was bought into, with the decline reversing from just above the crucial 22,700-22,800 zone,” stated Akshay Chinchalkar, Head of Analysis at Axis Securities. “The broader nse500, smallcap and midcap indices traced bullish engulfing pattens showing solid demand near the recent lows we have seen.”

“The market has to get out of the 22,700 – 23,300 zone for any real trend to begin, until which time, this churn is likely to continue,” he added.

In the meantime, Kunal Kamble, Senior Technical Analysis Analyst at Bonanza stated the “Nifty has remained range-bound for the past six sessions, trading between 23,200 and 22,700. A decisive breakout is required beyond these levels.”

“With today’s weekly expiry, the index is likely to close below 23,100, indicating continued consolidation unless a strong directional move emerges in the coming sessions,” he added.

Overseas Institutional Buyers (FIIs) have been web sellers, offloading ₹1,881.30 crore of equities in direction of the top, whereas Home Institutional Buyers (DIIs) remained web consumers just like the earlier session, shopping for ₹1,957.74 crore.

Among the many 30 Sensex shares, Tata Consultancy Companies dropped essentially the most by 2.28%, closing at ₹3,781.35. This was adopted by Infosys, which fell 2.20%, closing at ₹1,810.80, and Hindustan Unilever, which fell 1.98%, closing at ₹2,250.25.

17 out of the 30 Sensex shares have been within the crimson.

Among the many Nifty Sectoral Indices, the Nifty IT Index fell essentially the most by 1.30%, reaching 40,924.25, adopted by Nifty Healthcare, which fell 0.78%, reaching 13,363.85, and Nifty Pharma which was down 0.71%, closing at 20,820.00.

Nifty Healthcare and Pharma fell essentially the most on open as we speak and was within the crimson through the early commerce session as US President Donald Trump sought to impose a 25% tariff on Indian-made prescription drugs. The US is India’s largest export vacation spot of prescription drugs.

Nifty IT was dragged down by LTIMindtree (3.55% down), Tata Consultancy Companies (2.28% down), and Infosys (2.22% down).

Nifty Healthcare was dragged down by Dr. Reddy’s Laboratories (2.48% down), Zydus Lifesciences (2.21% down), and Aurobindo Pharma (2.13% down).

Nifty Pharma was dragged down by Natco Pharma (2.70% down), Dr. Reddy’s Laboratories (2.48% down), and Zydus Lifesciences (2.21% down).